JOSLIN DIABETES CT has a total of 15 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TAIVEX THERAPEUTICS CORP, RECORDATI S P A and HANGZHOU ZHUYANGXIN PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Heterocyclic compounds | |
#7 | Microorganisms | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Feener Edward P | 6 |
#2 | Clermont Allen | 3 |
#3 | Jing Enxuan | 3 |
#4 | Serwold Thomas | 2 |
#5 | Lee Richard T | 2 |
#6 | Wagers Amy | 2 |
#7 | Aiello Lloyd P | 2 |
#8 | King George Liang | 2 |
#9 | Chilcote Tamie Jo | 1 |
#10 | Kahn C Ronald | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016115496A1 | Metabolite biomarkers predictive of renal disease in diabetic patients | |
EP2956545A1 | Thymic regeneration | |
EP2369930A1 | Method for reducing blood pressure using inhibitors of plasma kallikrein | |
EP2259679A1 | Methods for treatment of kallikrein-related disorders | |
US2009142335A1 | Methods of diagnosis and treatment of metabolic disorders | |
WO2006104586A2 | Methods of diagnosis and treatment of metabolic disorders | |
WO0205810A1 | Modulation of nitric oxide synthase by pkc |